Evidence map›Paper›PMID 27757834›Full record

ArticleMolecular neurobiology2017

Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson's Disease.

Anelya Kh Alieva, Elena V Filatova, Anna A Kolacheva, Margarita M Rudenok, Petr A Slominsky, Mikhail V Ugrumov, Maria I Shadrina

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Development of an extended half-life GM-CSF fusion protein for Parkinson's disease.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Anelya Kh AlievaRussian Academy of Sciences, Institute of Molecular Genetics, 123182, pl. Kurchatova, 2, Moscow, Russia. anelja.a@gmail.com.
Elena V FilatovaRussian Academy of Sciences, Institute of Molecular Genetics, 123182, pl. Kurchatova, 2, Moscow, Russia.
Anna A KolachevaRussian Academy of Sciences, Koltzov Institute of Developmental Biology, 119334, ul. Vavilova, 26, Moscow, Russia.
Margarita M RudenokRussian Academy of Sciences, Institute of Molecular Genetics, 123182, pl. Kurchatova, 2, Moscow, Russia.
Petr A SlominskyRussian Academy of Sciences, Institute of Molecular Genetics, 123182, pl. Kurchatova, 2, Moscow, Russia.
Mikhail V UgrumovRussian Academy of Sciences, Koltzov Institute of Developmental Biology, 119334, ul. Vavilova, 26, Moscow, Russia.
Maria I ShadrinaRussian Academy of Sciences, Institute of Molecular Genetics, 123182, pl. Kurchatova, 2, Moscow, Russia.
Russian Academy of Sciences · RUKoltzov Institute of Developmental Biology · RUInstitute of Molecular Genetics · RUKurchatov Institute · RU

Funding

Russian Foundation for Basic Research 15-04-05606Russian Foundation for Basic Research 16-34-00200
6 · The paper itself

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative diseases. Despite progress in the study of the molecular, genetic, and pathogenic mechanisms of PD, it is unclear which processes trigger the development of the pathology associated with PD. Models of the presymptomatic and early symptomatic stages of PD induced by MPTP have been used to analyze changes in transcriptome profile in brain tissues, to identify specific patterns and mechanisms underlying neurodegeneration in PD. The whole-transcriptome analysis in the brain tissues of the mice with MPTP-induced PD showed that striatum is involved in the pathogenesis in the earliest stages and the processes associated with vesicular transport may be altered. The expression profiles of the genes studied in the substantia nigra and peripheral blood confirm that lymphocytes from peripheral blood may reflect processes occurring in the brain. These data suggest that messenger RNA (mRNA) levels in peripheral blood may provide potential biomarkers of the neurodegeneration occurring in PD. The changes in expression at the mRNA and protein levels suggest that Snca may be involved in neurodegeneration and Drd2 may participate in the development of the compensatory mechanisms in the early stages of PD pathogenesis. Our data suggest that the brain cortex may be involved in the pathological processes in the early stages of PD, including the presymptomatic stage.

Indexed as

AnimalsGene Expression ProfilingMaleMiceMice, Inbred C57BLMPTP PoisoningDRD2Gene expressionMPTPMPTP modelParkinson’s diseaseSNCAWhole-transcriptome analysis

Identifiers

PMID27757834
OpenAlexW2537465346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.